Annual report
6776.TEDINET S100TU9G
Period2023-04-01 → 2024-03-31
Filed2024-06-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥26.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥23.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥19.4bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥15.6bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥18.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.1bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥604m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.3bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥752m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥355m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥298m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.4bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥767m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥948m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥612m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥246m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥158m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥700m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.0bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥578m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥28.0bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥27.6bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥21.3bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥17.3bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥17.1bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥17.0bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥18.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.9bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥9.5bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥8.1bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥7.2bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥7.1bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.2bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.3bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.1bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥3.0bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.4bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.0bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.3bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.9bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.1bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥622m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥2.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥545m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥496m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥74m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥55.77 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.99 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.47 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.34 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.6 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥543.6 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥465.86 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥415.13 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥396.84 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥389.44 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 33.1% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.0% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.8% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 11.1% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.2% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.6% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.4% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.2% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 720 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 698 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 691 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 537 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 549 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥17.1bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥16.0bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥13.8bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥13.7bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥16.2bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥693m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥518m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥931m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥677m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥242m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥322m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥885m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.0bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥695m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥760m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥514m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥177m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥232m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥644m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥18.7bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥17.8bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥17.4bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥16.5bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥16.4bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥10.4bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥10.3bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥8.3bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.5bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.0bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥6.9bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥6.6bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥3.2bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.3bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥44.7 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.21 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.43 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.66 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.29 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥5 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥489.51 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥440.3 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥411.58 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥404.22 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥389.51 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 44.5% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.1% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.2% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.6% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.5% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 9.6% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.1% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.6% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.4% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.3% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 17,014,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,014,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,014,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,014,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 17,014,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 373 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 389 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 398 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 406 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 404 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 80
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | −¥4m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2024-03-31 | −¥152m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2024-03-31 | −¥152m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | −¥2.3bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | ¥6m |
| Injection Molding Business In Americareportable segment | capex | 2023-04-01 → 2024-03-31 | ¥247m |
| Injection Molding Business In Americareportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥470m |
| Injection Molding Business In Americareportable segment | employees | at 2024-03-31 | 273 pure |
| Injection Molding Business In Americareportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥5.9bn |
| Injection Molding Business In Americareportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥5.9bn |
| Injection Molding Business In Americareportable segment | segment assets | at 2024-03-31 | ¥9.0bn |
| Injection Molding Business In Americareportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥240m |
| Injection Molding Business In Chinareportable segment | capex | 2023-04-01 → 2024-03-31 | ¥31m |
| Injection Molding Business In Chinareportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥9m |
| Injection Molding Business In Chinareportable segment | employees | at 2024-03-31 | 23 pure |
| Injection Molding Business In Chinareportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥556m |
| Injection Molding Business In Chinareportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥445m |
| Injection Molding Business In Chinareportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥110m |
| Injection Molding Business In Chinareportable segment | segment assets | at 2024-03-31 | ¥573m |
| Injection Molding Business In Chinareportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥9m |
| Injection Molding Business In Japanreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥2.2bn |
| Injection Molding Business In Japanreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥1.7bn |
| Injection Molding Business In Japanreportable segment | employees | at 2024-03-31 | 401 pure |
| Injection Molding Business In Japanreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥20.3bn |
| Injection Molding Business In Japanreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥20.2bn |
| Injection Molding Business In Japanreportable segment | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥42m |
| Injection Molding Business In Japanreportable segment | segment assets | at 2024-03-31 | ¥20.4bn |
| Injection Molding Business In Japanreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥568m |
| Real Estate Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥17m |
| Real Estate Businessreportable segment | employees | at 2024-03-31 | 1 pure |
| Real Estate Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥284m |
| Real Estate Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥284m |
| Real Estate Businessreportable segment | segment assets | at 2024-03-31 | ¥263m |
| Real Estate Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥237m |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥2.5bn |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥2.2bn |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥27.1bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥26.9bn |
| —segment total | revenue intersegment | 2023-04-01 → 2024-03-31 | ¥152m |
| —segment total | segment assets | at 2024-03-31 | ¥30.3bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥1.1bn |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | −¥7m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | −¥79m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥79m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | −¥2.6bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | ¥7m |
| Injection Molding Business In Americareportable segment | capex | 2022-04-01 → 2023-03-31 | ¥3.6bn |
| Injection Molding Business In Americareportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥184m |
| Injection Molding Business In Americareportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥3.6bn |
| Injection Molding Business In Americareportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥3.6bn |
| Injection Molding Business In Americareportable segment | segment assets | at 2023-03-31 | ¥9.8bn |
| Injection Molding Business In Americareportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥132m |
| Injection Molding Business In Chinareportable segment | capex | 2022-04-01 → 2023-03-31 | ¥13m |
| Injection Molding Business In Chinareportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥12m |
| Injection Molding Business In Chinareportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥770m |
| Injection Molding Business In Chinareportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥729m |
| Injection Molding Business In Chinareportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥40m |
| Injection Molding Business In Chinareportable segment | segment assets | at 2023-03-31 | ¥663m |
| Injection Molding Business In Chinareportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥71m |
| Injection Molding Business In Japanreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥1.6bn |
| Injection Molding Business In Japanreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥1.7bn |
| Injection Molding Business In Japanreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥19.3bn |
| Injection Molding Business In Japanreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥19.3bn |
| Injection Molding Business In Japanreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥38m |
| Injection Molding Business In Japanreportable segment | segment assets | at 2023-03-31 | ¥19.4bn |
| Injection Molding Business In Japanreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥423m |
| Real Estate Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥23m |
| Real Estate Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥287m |
| Real Estate Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥287m |
| Real Estate Businessreportable segment | segment assets | at 2023-03-31 | ¥281m |
| Real Estate Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥233m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥5.2bn |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥24.0bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥23.9bn |
| —segment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥79m |
| —segment total | segment assets | at 2023-03-31 | ¥30.1bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥597m |
| Injection Molding Business In Japanreportable segment | employees | at 2024-03-31 | 350 pure |
| Real Estate Businessreportable segment | employees | at 2024-03-31 | 1 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,520
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithFullVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 17008100 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 170081 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 5900 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 17014000 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 170081 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 85000000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 5 | |
| Number of male directors and other officers | FilingDateInstant | 11 | |
| Number of female directors and other officers | FilingDateInstant | － | |
| Ratio of female directors and other officers | FilingDateInstant | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000FujimotoKensukeMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000TadahikoIshikawaMember | 219000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000MisaoSugiyamaMember | 2000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000YasuhiroImaoMember | 1000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000IsamuKishidaMember | 2000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000KaoruGotoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000RyuichiKomatsuzakiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000SusumuKandaMember | 1000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000HiroyukiSakamotoMember | 1000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000TakashiTsudaMember | 23000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E01813-000HitoshiMouriMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 251000 | |
| Audit fees reporting company | Prior1YearDuration | 31000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | － | JPY |
| Audit fees reporting company | CurrentYearDuration | 32000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | － | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
| Audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Non audit fees consolidated subsidiaries | CurrentYearDuration | － | JPY |
| Audit fees total | Prior1YearDuration | 31000000 | JPY |
| Non audit fees total | Prior1YearDuration | － | JPY |
| Audit fees total | CurrentYearDuration | 32000000 | JPY |
| Non audit fees total | CurrentYearDuration | － | JPY |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 45000000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 45000000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | － | JPY |
| Retirement benefits remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_DirectorsExcludingOutsideDirectorsMember | 4 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 4000000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 4000000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
| Retirement benefits remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_CorporateAuditorsExcludingOutsideCorporateAuditorsMember | 1 | |
| Total amount of remuneration etc remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 12000000 | JPY |
| Fixed remuneration remuneration by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 12000000 | JPY |
| Performance based remuneration remuneration by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | － | JPY |
| Retirement benefits remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | － | JPY |
| Number of directors and other officers remuneration etc by category of directors and other officers | CurrentYearDuration_OutsideDirectorsAndOtherOfficersMember | 4 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |